Investor RelationsCOVID-19
  1. Home
  2. Medical Imaging
  3. Molecular Imaging
Biograph Vision

Molecular Imaging

Answering to clinical needs in oncology, neurology, cardiology, and radiology, Siemens Healthineers Molecular Imaging systems provide PET/CT, SPECT, and hybrid SPECT scanner (SPECT/CT) solutions to help clinicians diagnose, treat, and monitor disease more confidently.

Nuclear Medicine News & Stories

By Sameh Fahmy

Theranostics for neuroendocrine tumors: A patient’s experience

 2024-12-02

After receiving the diagnosis of neuroendocrine tumors, Glenda’s oncologist was unable to provide effective treatment options. Considering her disease burden and noting the progression of the tumors that were difficult to surgically remove, Glenda was referred for theranostics treatment. 

News
By Sameh Fahmy

Theranostics center of excellence: transforming oncology care

 2024-12-01
Nebraska Cancer Specialists in the midwestern region of the United States serves as a model of excellence in theranostics. While caring for the local community and attracting patients from across the country, the center also operates an extensive clinical trials program.
News
By Catherine Marcic Joyce

Highlights from the EANM 2024 Annual Congress

 2024-11-15

The European Association of Nuclear Medicine’s 37th Annual Meeting took place October 19–23, 2024, in Hamburg, Germany.

News

By Claudette Lew

PET/CT biomarkers enable clinicians to advance Alzheimer’s disease care

 2024-09-19
With the latest molecular imaging tools and biomarkers to enhance diagnostic accuracy and enable disease-modifying treatments, clinicians are paving the way for Alzheimer's disease care.
News

By Dr. K. G. Kallur, Noby Varghese, Abhinav Shanker, Ramya Rajaram

India’s increasing patient population benefits from operational excellence

 2024-06-28
An oncology team in Bengaluru, India, explains how they maximize their PET/CT scanner’s capabilities to better serve their increasing oncology patient population.
News
* Biograph Vision is not commercially available in all countries. Due to regulatory reasons, its future availability cannot be guaranteed. Please contact your local Siemens organization for further details.
1
syngo.PET Amyloid Plaque is intended for use only with approved amyloid radiopharmaceuticals in the country of use. Users should review the drug labeling for approved uses.